Full-Time
Investment Operations Analyst
Posted on 3/11/2025
MicroVentures
51-200 employees
Equity crowdfunding platform for startups
No salary listed
Entry, Junior
Austin, TX, USA
This position is hybrid, indicating that the candidate will need to work in the office part of the time.
- Bachelor’s degree in accounting, finance, or economics
- At least one year of work experience, preferably within the financial industry
- Strong organizational and documentation skills
- Strong verbal and written communication skills
- Keen eye for details to identify trends, cause and effects
- Ability to manage multiple tasks and priorities at once
- Strategic thinker focused on continuous improvement
- Professional demeanor and strong work ethic
- Proficiency with Office Suite, especially Excel (formulas, macros, pivot tables, etc.)
- Assist in the establishment and maintenance of over 800 Venture Funds
- Prepare investor notices, including capital call, fee, and distribution notices
- Process outgoing and incoming payments
- Maintain key databases to fulfill ad-hoc requests for Fund and investor data
- Participate on special projects related to the fund
- Assist in the preparation of applicable tax forms (e.g., Form 1065)
- Ensure compliance with regulatory requirements and other requirements of the funds’ specifications
- Collaborate with compliance, operations, and executive leadership teams to meet all requirements to the highest standards of quality
MicroVentures operates an equity crowdfunding platform that allows both accredited and non-accredited investors to invest in high-growth startups and private market opportunities. The platform simplifies the investment process by providing access to early-stage investment opportunities that were once limited to venture capitalists and institutional investors. MicroVentures generates revenue through a dual-fee structure, where investors pay a fee based on their investment amount, and companies pay a fee to list their fundraising campaigns. Additionally, the company offers educational resources to help investors understand the risks and make informed decisions about equity crowdfunding. This focus on accessibility and education sets MicroVentures apart from its competitors in the fintech market.
Company Size
51-200
Company Stage
N/A
Total Funding
$3.2M
Headquarters
Austin, Texas
Founded
2009
Simplify's Take
What believers are saying
- Growing interest in sustainable housing solutions presents new investment opportunities for MicroVentures.
- The rise of 3D printing in healthcare offers potential investment avenues for MicroVentures.
- Anfin's success in democratizing stock investing aligns with MicroVentures' mission.
What critics are saying
- Increased competition from new crowdfunding platforms could attract investors away from MicroVentures.
- Decentralized finance platforms pose a threat to traditional equity crowdfunding models.
- Regulatory scrutiny on equity crowdfunding platforms may increase operational costs.
What makes MicroVentures unique
- MicroVentures connects both accredited and non-accredited investors with early-stage startups.
- The platform offers a dual-fee structure, generating revenue from both investors and companies.
- MicroVentures provides educational resources to help investors understand equity crowdfunding risks.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Company News
Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
BOSTON, Aug. 15, 2022 /PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded seed round financing. Funding from the raise is being used to study Remedium's lead product, a single-injection gene therapy potentially capable of reversing cartilage loss, in a collaboration with Tufts University School of Medicine scientists researching rheumatic disorders. The financing was led by Sherwood Ventures and included participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels, MicroVentures, and Guindy Alumni Angels. Potential to reverse years of age-related cartilage loss Tweet this We believe that any disease can be cured. - Remedium Bio